Medacta Opens Franklin Headquarters


Tennessee Gov. Bill Lee and Chief Executive Officer of Medacta International Francesco Siccardi announced the official opening of Medacta’s US headquarters in Franklin. Medacta USA is a subsidiary of Medacta® International, a global company specializing in the design and production of innovative joint replacement and spine surgery products. 

Medacta USA will invest $2.5 million and create more than 50 jobs in Franklin. The new U.S. headquarters at 6640 Carothers Pkwy, Suite 420, Franklin, TN, will house the company’s Total Joint (Hip, Knee & Shoulder), Spine & Sports Medicine divisions serving North America.

“Medacta USA’s decision to bring its U.S. headquarters to Franklin underscores the vibrant economy of the entire Nashville region. Tennessee’s business-friendly environment gives companies of all types the opportunity to create quality jobs for our residents, especially in the health care sector. I thank Medacta for this investment in Williamson County,” said Gov. Bill Lee.

Established in 1999 in Switzerland, Medacta’s products and surgical techniques have made a significant impact in the global orthopaedic market. Medacta is a pioneer in developing new offerings to support minimally invasive surgical techniques with a strong commitment to provide ongoing clinical education programs and products that enhance healthcare system sustainability worldwide. 

“Today we take another step in our company’s growth evolution,” said Francesco Siccardi, Chief Executive Officer of Medacta International. “This year Medacta is celebrating its 20-year anniversary and recently becoming a public company with shares available for purchase on the Swiss Exchange. In 2018, we were among the fastest growing orthopedic companies, and opening our North American headquarters here in Franklin, Tennessee is a testament to the impact we made on the orthopaedic market globally. We are grateful for the community’s warm welcome and look forward to becoming an active and visible member of it.”

The announcement was made in conjunction with an open house and ribbon cutting ceremony at Medacta USA’s new headquarters. The event highlighted recent company milestones as well as Medacta’s commitment to responsible innovation that benefits patients, doctors, and the healthcare system at large. 

Industry partners, advocates, clinicians, and employees heard from company executives and Franklin city officials on the importance of the move to Medacta’s long-term potential and the company’s newly added value to the region’s technology and medical ecosystem. 

Following the official ceremonies, attendees were invited to participate in a “Meet the Expert” reception and Product Showcase conducted by the Medacta Orthopedic Research and Education (M.O.R.E) Institute. The reception opened a two-day educational forum where surgeons from the US and Mexico receive intensive didactic and cadaveric training on the safe and effective use of Medacta’s joint replacement and spine products. 

Medacta’s mission is to transform the patient experience by advancing surgical approaches, implants and instruments through responsible innovation and meticulous design. The company’s innovation began with minimally invasive techniques and has evolved into personalized solutions for every patient. Today, Medacta utilizes cutting-edge technologies such as 3D printing, invests in medical education, research and development, and collaborates with surgeons and universities worldwide.

About Medacta International

Medacta is an international orthopaedics company specializing in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta’s products and surgical techniques are characterized by innovation. Medacta is a pioneer in developing new offerings based on minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery (“AMIS”) technique for hip replacements. Medacta has leveraged its orthopaedic expertise and comprehensive understanding of the human body to develop the sophisticated “MySolutions” technology, which offers surgeons highly personalized pre-operative planning and implant placement methodologies by creating advanced personalized kinematic models and 3D planning tools for use in hip, knee, shoulder and spine procedures. Medacta is headquartered in Castel San Pietro, Switzerland, and Rancate, Switzerland, and employs approximately 970 people. Visit for more information.